N
Power Law company profile
Nykode Therapeutics
Biotech & Life Sciences · Oslo, Norway · Founded 2007 · IPO 2020 Unicorn
Valuation
$56M
Market cap · Apr/2026
Global footprint
Where Nykode Therapeutics has talent and traffic
Web traffic by country
3.9K
monthly visits
across markets
across markets
🇳🇴 Norway79.5%
🇺🇸 United States20.5%
Patent intelligence
$16M patent portfolio · 5 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$16M
29.1% of market cap · 1.6× the top peer Affinivax ($10M)
5 active patent families
Where Nykode Therapeutics innovates
TGE VACCINECarcinosisAntigen-presenting cellCancer vaccineNeo epitope
Above peer median on Market · Below peer median on Legal, Strategic
Quality vs same-sector peers
Nykode Therapeutics on the five Patsnap quality dimensions
Nykode Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Nykode Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Nykode Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Nykode Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.